• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    GlycoMimetics, Inc. (GLYC)

    7.05 Down 0.03(0.42%) Aug 28, 4:00PM EDT
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    Market Cap:134.08M76.90MN/A101.07BN/A
    Qtrly Rev Growth (yoy):0.33N/AN/A0.07N/A
    Revenue (ttm): 20.04MN/A41.46B116.38BN/A
    Gross Margin (ttm):1.00N/AN/A0.77N/A
    EBITDA (ttm):-10.65M-33.95MN/A4.63BN/A
    Operating Margin (ttm): -0.54N/AN/A0.24N/A
    Net Income (ttm):-10.73M-34.95M5.34B11.79BN/A
    EPS (ttm):-0.57-0.24N/A1.07N/A
    P/E (ttm):N/AN/AN/A56.59N/A
    PEG (5 yr expected):N/AN/AN/A1.66N/A
    P/S (ttm):6.72N/AN/A6.19N/A
    MSTX = Mast Therapeutics, Inc.
    Pvt1 = SANOFI
    BMY = Bristol-Myers Squibb Company
    1 = As of 2014  

    News on Direct Competitors 

    Currency in USD.